Technical Analysis for TLC - Taiwan Liposome Company, Ltd.

Grade Last Price % Change Price Change
grade F 5.82 -1.85% -0.11
TLC closed down 1.85 percent on Thursday, April 18, 2019, on 5 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Very Strong N/A Down Flat
See historical TLC trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Fell Below 50 DMA Bearish 0.00%
Narrow Range Bar Range Contraction 0.00%
Gapped Down Weakness 0.00%
Crossed Above 20 DMA Bullish -1.85%
Crossed Above 50 DMA Bullish -1.85%
Upper Bollinger Band Touch Strength -1.85%
20 DMA Resistance Bearish -0.17%
Gapped Up Strength -0.17%
Narrow Range Bar Range Contraction -0.13%

Older signals for TLC ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Taiwan Liposome Company, Ltd., a biopharmaceutical company, engages in the research, development, and commercialization of lipid-based pharmaceutical products. The company offers products in the areas of oncology, ophthalmology, peripheral arterial disease, fungal infection, anesthetic, and arthritis indications. Its products include Lipotecan, an anti-cancer camptothecin drug; Doxisome, a liposomal encapsulated formulation of doxorubicin; TLC178, a liposomal encapsulated formulation of vinorelbine; ProDex, an ophthalmic drug for the treatment of macular edema; ProFlow, an emulsion form of prostaglandin E1; AmBiL, a liposomal encapsulated formulation of amphotericin B; TLC198, a liposomal encapsulated bupivacaine, enabling the sustained release of a constant amount of local anesthetic; and TLC599, a corticosteroid encapsulated in lipid based drug delivery system for the treatment of inflammation caused by arthritis. The company was founded in 1997 and is headquartered in Taipei City, Taiwan.
Biopharmaceutical Drugs Inflammation Pharmacology Drug Delivery Arthritis Macular Edema Doxorubicin Peripheral Arterial Disease Amphotericin B Arbutus Biopharma Bupivacaine Liposome
Is TLC a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 11.0
52 Week Low 5.02
Average Volume 3,741
200-Day Moving Average 0.0
50-Day Moving Average 5.921
20-Day Moving Average 5.8426
10-Day Moving Average 5.8312
Average True Range 0.1536
ADX 53.86
+DI 33.6512
-DI 10.4791
Chandelier Exit (Long, 3 ATRs ) 5.6392
Chandelier Exit (Short, 3 ATRs ) 6.1608
Upper Bollinger Band 5.9497
Lower Bollinger Band 5.7355
Percent B (%b) 0.39
BandWidth 3.666176
MACD Line -0.0244
MACD Signal Line -0.0374
MACD Histogram 0.013
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.82
Resistance 3 (R3) 5.82 5.82 5.82
Resistance 2 (R2) 5.82 5.82 5.82 5.82
Resistance 1 (R1) 5.82 5.82 5.82 5.82 5.82
Pivot Point 5.82 5.82 5.82 5.82 5.82
Support 1 (S1) 5.82 5.82 5.82 5.82 5.82
Support 2 (S2) 5.82 5.82 5.82 5.82
Support 3 (S3) 5.82 5.82 5.82
Support 4 (S4) 5.82